These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3899664)

  • 21. [Combination of oxybutynin chloride (Ditropan) with intermittent catheterization in the treatment of neurogenic bladder in childhood: results on continence].
    De Castro R; Casolari E; Ricci S
    Pediatr Med Chir; 1984; 6(6):795-803. PubMed ID: 6545593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravesical oxybutinin chloride in children with intermittent catheterization: sonographic findings.
    Zerin JM; DiPietro MA; Ritchey ML; Bloom DA
    Pediatr Radiol; 1994; 24(5):348-50. PubMed ID: 7824373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oxybutynin chloride in the management of idiopathic detrusor instability.
    Paulson DF
    South Med J; 1979 Mar; 72(3):374-5. PubMed ID: 424842
    [No Abstract]   [Full Text] [Related]  

  • 24. Spina bifida occulta in functional enuresis.
    Kumar P; Aneja S; Kumar R; Taluja V
    Indian J Pediatr; 2005 Mar; 72(3):223-5. PubMed ID: 15812117
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oxybutynin and incontinence during grand mal seizures.
    Harari D; Malone-Lee JG
    Br J Urol; 1991 Dec; 68(6):658. PubMed ID: 1773301
    [No Abstract]   [Full Text] [Related]  

  • 26. Is spina bifida occulta associated with lower urinary tract dysfunction in children?
    Samuel M; Boddy SA
    J Urol; 2004 Jun; 171(6 Pt 2):2664-6. PubMed ID: 15118447
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prophylactic value of clean intermittent catheterization and anticholinergic medication in newborns and infants with myelodysplasia at risk of developing urinary tract deterioration.
    Kasabian NG; Bauer SB; Dyro FM; Colodny AH; Mandell J; Retik AB
    Am J Dis Child; 1992 Jul; 146(7):840-3. PubMed ID: 1496955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravesical oxybutynin chloride: experience with 42 patients.
    Weese DL; Roskamp DA; Leach GE; Zimmern PE
    Urology; 1993 Jun; 41(6):527-30. PubMed ID: 8516987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of spina bifida occulta in patients with functional disorders of the lower urinary tract and its relation to urodynamic and neurophysiological measurements.
    Fidas A; MacDonald HL; Elton RA; McInnes A; Wild SR; Chisholm GD
    BMJ; 1989 Feb; 298(6670):357-9. PubMed ID: 2493933
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of bowel management in alleviating symptoms of urinary incontinence in patients with spina bifida associated with overactive bladder and detrusor sphincter dyssynergia.
    Radojicic Z; Milivojevic S; Milic N; Lazovic JM; Lukac M; Sretenovic A
    BJU Int; 2019 Jan; 123(1):118-123. PubMed ID: 29802783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. McCreadie Travelling Scholarship tour report. Aims to improve continence in spina bifida.
    Hoath L
    Lamp; 1979 Feb; 36(1):21-4. PubMed ID: 372698
    [No Abstract]   [Full Text] [Related]  

  • 32. Intravesical instillation of oxybutynin hydrochloride therapy for patients with a neuropathic bladder.
    Mizunaga M; Miyata M; Kaneko S; Yachiku S; Chiba K
    Paraplegia; 1994 Jan; 32(1):25-9. PubMed ID: 8015832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical features of spina bifida occulta with neurological deficit (author's transl)].
    Ohtsuka K
    Nihon Seikeigeka Gakkai Zasshi; 1979 May; 53(5):505-19. PubMed ID: 158622
    [No Abstract]   [Full Text] [Related]  

  • 34. The Relationship Between Nocturnal Enuresis and Spina Bifida Occulta: A Prospective Controlled Trial.
    Yavuz A; Bayar G; Kilinc MF; Sariogullari U
    Urology; 2018 Oct; 120():216-221. PubMed ID: 30099128
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [New training proposal: self catheterization for children and adolescents with spina bifida. Interview by Inger Syrstad].
    Sommer F; Kalvik AM
    Sykepleien; 1983 Dec; 70(21):18. PubMed ID: 6362050
    [No Abstract]   [Full Text] [Related]  

  • 36. Occult spinal dysraphism: clinical and urodynamic outcome after division of the filum terminale.
    Khoury AE; Hendrick EB; McLorie GA; Kulkarni A; Churchill BM
    J Urol; 1990 Aug; 144(2 Pt 2):426-8; discussion 428-9, 443-4. PubMed ID: 2197434
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The enema continence catheter in spina bifida: successful bowel management.
    Shandling B; Gilmour RF
    J Pediatr Surg; 1987 Mar; 22(3):271-3. PubMed ID: 3550032
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spina bifida: a new disease.
    Leonard CO; Freeman JM
    Pediatrics; 1981 Jul; 68(1):136-7. PubMed ID: 7017581
    [No Abstract]   [Full Text] [Related]  

  • 39. Continence: independence for the handicapped child.
    White M
    Nurs Times; 1990 Feb 14-20; 86(7):69-72. PubMed ID: 2179881
    [No Abstract]   [Full Text] [Related]  

  • 40. Detrusor overactivity in spina bifida: how long does it need to be treated?
    Ab E; Dik P; Klijn AJ; van Gool JD; de Jong TP
    Neurourol Urodyn; 2004; 23(7):685-8. PubMed ID: 15382196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.